Abstract
Objective-To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy. Design-Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease. Setting-University virology department and transplantation unit. Methods-Reverse transcriptase-polymerase chain reaction and nucleotide sequence analysis of myocardial RNA and DNA; enterovirus-specific in situ hybridisation; enterovirus-specific immunoglobulin M detection. Results-Enterovirus RNA was detected in myocardial tissue from only a small proportion of (five of 75) hearts. However, although enterovirus-specific immunoglobulin M responses were detected in 22 (28%) of 39 controls patients, a significantly higher prevalence was observed among patients with dilated cardiomyopathy (22 (56%) of 39 patients; P < 0.005). All Although it is now well established that enteroviruses, particularly group B coxsackieviruses, are the commonest viral cause of acute myocarditis,' their role in dilated cardiomyopathy is controversial. Serological studies showed that, compared with controls, patients with dilated cardiomyopathy had significantly higher enterovirus neutralising antibody titres than controls,2 and a higher incidence of enterovirus-specific immunoglobulin M responses34 which persisted for many months or years in some patients,3 suggesting a persisting antigenic stimulus.
Although infectious virus or viral antigens cannot be detected in the myocardium of patients with dilated cardiomyopathy, molecular biological techniques have been used successfully to detect enterovirus RNA in such tissue. In studies using RNA hybridisation, enterovirus RNA was found in biopsies from 30-41% of patients with dilated cardiomyopathy and in explanted recipient myocardium from 16-29% of patients with end-stage dilated cardiomyopathy undergoing cardiac transplantation, but only rarely in control or comparison group patients.7 The results of some studies employing reverse transcriptionpolymerase chain reaction (PCR) support this association8-'0 whereas others do not, either failing to detect enterovirus RNA in patients with dilated cardiomyopathy, or finding enterovirus RNA in similar proportions of patients and controls (reviewed by Muir'1).
These investigations, however, used a wide range of techniques, often of undefined sensitivity and specificity, which measure different biological indices of enterovirus infection. In addition, the classification and stage of dilated cardiomyopathy in the study population may have been variable, and control or comparison groups were selected from different clinical categories. The extent to which these factors are responsible for discrepancies in the observed association between enterovirus infection and dilated cardiomyopathy is unknown. Furthermore few studies used a range of different molecular biological and serological investigations to study the same patients and controls.
We therefore studied a single group of patients with dilated cardiomyopathy and patients with other cardiological disease serv-ing as controls, using enterovirus-specific immunoglobulin M serology, reverse transcriptase-PCR, and in situ hybridisation assays to determine the relative diagnostic value of these assays in patients with dilated cardiomyopathy. Where enteroviruses were detected by reverse transcriptase-PCR, we determined the nucleotide sequence of representative PCR products derived from three non-overlapping regions of the viral genome in order to identify the enterovirus serotype detected and to exclude cross contamination with viral RNA or complementary DNA from other clinical samples, PCR reactions, or laboratory-propagated enterovirus strains or complementary DNA clones.
The primary site of enterovirus replication is the mucosal tissue of the gastrointestinal tract, and acute infection is frequently accompanied by viral shedding in throat secretions and stools. Because we previously showed that a high proportion of patients with dilated cardiomyopathy had persistent enterovirus-specific immunoglobulin A responses,' we also attempted to determine whether enteroviruses persisted in intestinal mucosal tissue by examining stools for the presence of infectious enteroviruses and enteroviral RNA.
Because other viruses may also induce acute myocarditis, we also examined by PCR a number of heart samples for the presence of other potentially cardiotropic viruses such as human cytomegalovirus,"2 influenzaviruses,"3 and human coronaviruses."4 15 Patients and methods
PATIENTS AND SPECIMENS
Patients with end-stage cardiac or respiratory failure undergoing heart or combined heart/ lung transplantation at Papworth Hospital were included in the study. Serum was collected at the time of transplantation from 118 patients. The cause of heart failure was generally already established at the time of transplantation, and was confirmed by pathological examination of the excised heart and/or lung. Dilated cardiomyopathy was diagnosed in accordance with WHO/ISFC criteria'6 in 39 patients (33%). The remaining 79 (67%) had other myocardial or pulmonary disease, including ischaemic heart disease (55 patients), cystic fibrosis (seven patients), Eisenmenger's complex (three patients), primary pulmonary hypertension (six patients), and other heart-lung disease (eight patients). Portions 
PRIMERS
Polymerase chain reaction primers for amplification of two distinct regions of the 5' nontranslated region and part of the viral polypeptide-2 capsid-coding region of the enterovirus genome have been described previously. 17-19 Primers for amplification of cytomegalovirus DNA were described by Darlington et al. 20 Primers for amplification of influenzavirus RNA were designed to amplify regions of the non-structural gene segment of influenzavirus types A, B, and C, which are conserved between strains within each serotype. Primers were designed using published virus gene sequences. Primers for detection of influenzavirus types A and B were used in a single multiplex PCR. Primers for detection of human coronaviruses were designed to amplify part of the 3' non-translated region of the nucleocapsid gene, which is common to all viral mRNA species as well as viral genomic RNA, based on published nucleocapsid gene sequences of human coronavirus strains 229E and OC43, and were also used in a single multiplex PCR. All primers used are shown in table 1. Optimal primer sequences were predicted using OLIGO 4 0 (National Biosciences). Primers were synthesised by R & D Systems (Europe) or Pharmacia Biotech.
POLYMERASE CHAIN REACTION ASSAYS
Total RNA was extracted from 100 Ml of virus stock or stool filtrate, or from about 100 mg portions of cryopreserved myocardium using RNAzol B (Cinna Biotecx, Houston, Texas) as described previously,'7 and tested for the presence of enterovirus, influenzavirus, and human coronavirus RNA by reverse transcriptase-PCR. Nested and semi-nested reverse transcriptase-PCR assays for detection of enterovirus RNA have been described previously.'8'9 All myocardial samples were examined using both primer sets which amplify regions of the 5' non-translated region of the enterovirus genome. Those in which enterovirus RNA was detected by one or both Serological and molecular evidence ofenterovirus infection in patients with end-stage dilated cardiomyopathy Southern blot hybridisation was used to confirm the identity of cytomegalovirus, influenzavirus, and human coronavirus PCR products. Southern blotting was performed as described previously,'7 and hybridisation was performed using digoxygenin-1 1-deoxy-uridine triphosphate-labelled PCR products derived from reference virus strains as hybridisation probes and a digoxygenin detection kit (Boehringer Mannheim) according to the manufacturer's protocol. 
NUCLEOTIDE SEQUENCE ANALYSIS
The nucleotide sequence of biotinylated nested PCR products generated using primers EVU2 and EVD2 was determined by direct solidphase sequencing as described previously. '9 Other enterovirus PCR products to be sequenced were cloned in pGEM-T vector, and sequenced using fluorescein-labelled T7 or SP6 RNA polymerase promoter-specific sequencing primers with an Autoread sequencing kit and ALF DNA sequencer (Pharmacia). Nucleotide sequences were compared with published sequences of standard enterovirus strains using DNASIS to determine the serotypic identity of enteroviruses detected.
IN SITU HYBRIDISATION
Replicate sections of formalin-fixed recipient myocardium (5 pm thick) were examined for the presence of enterovirus RNA by in situ hybridisation using digoxygenin-labelled enterovirus-specific and control probes as described previously.'9
VIRUS ISOLATION
Enterovirus isolation from stool samples was attempted by inoculation of stool filtrate into Vero, monkey kidney, and human embryo fibroblast cell cultures, which were observed for cytopathic effect for two, three, and four weeks respectively before being regarded as negative. 
Results
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